Literature DB >> 21829102

Phosphoproteomics microarray screen reveals novel interaction between MPL and Tensin2: implications for biology, disease and therapeutics.

Jeffrey W Tyner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21829102      PMCID： PMC3356797          DOI： 10.4161/cc.10.16.16391

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  9 in total

Review 1.  The molecular mechanisms that control thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

2.  A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors.

Authors:  M Souyri; I Vigon; J F Penciolelli; J M Heard; P Tambourin; F Wendling
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

3.  Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.

Authors:  K Muraoka; E Ishii; K Tsuji; S Yamamoto; H Yamaguchi; T Hara; H Koga; T Nakahata; S Miyazaki
Journal:  Br J Haematol       Date:  1997-02       Impact factor: 6.998

4.  Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily.

Authors:  I Vigon; J P Mornon; L Cocault; M T Mitjavila; P Tambourin; S Gisselbrecht; M Souyri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  Tensin2 is a novel mediator in thrombopoietin (TPO)-induced cellular proliferation by promoting Akt signaling.

Authors:  Andre Scott Jung; Alexis Kaushansky; Gavin Macbeath; Kenneth Kaushansky
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

6.  Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin.

Authors:  K Kaushansky; S Lok; R D Holly; V C Broudy; N Lin; M C Bailey; J W Forstrom; M M Buddle; P J Oort; F S Hagen
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

7.  Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin.

Authors:  Jianmin Ding; Hirokazu Komatsu; Atsushi Wakita; Miyuki Kato-Uranishi; Masato Ito; Atsushi Satoh; Kazuya Tsuboi; Masakazu Nitta; Hiroshi Miyazaki; Shinsuke Iida; Ryuzo Ueda
Journal:  Blood       Date:  2004-02-05       Impact factor: 22.113

8.  RNAi screen for rapid therapeutic target identification in leukemia patients.

Authors:  Jeffrey W Tyner; Michael W Deininger; Marc M Loriaux; Bill H Chang; Jason R Gotlib; Stephanie G Willis; Heidi Erickson; Tibor Kovacsovics; Thomas O'Hare; Michael C Heinrich; Brian J Druker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

9.  MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.

Authors:  Yana Pikman; Benjamin H Lee; Thomas Mercher; Elizabeth McDowell; Benjamin L Ebert; Maricel Gozo; Adam Cuker; Gerlinde Wernig; Sandra Moore; Ilene Galinsky; Daniel J DeAngelo; Jennifer J Clark; Stephanie J Lee; Todd R Golub; Martha Wadleigh; D Gary Gilliland; Ross L Levine
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.